Search

Author/Creator Néri, C

2. A10 SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. (16th November 2010)

Authors:
Taylor, D; Pallos, J; Lambert, E; Amore, A; Parker, A; Moffitt, H; Smith, D; Runne, H; Gokce, O; Kuhn, A; Xiang, Z; Maxwell, M; Reeves, S; Bates, G; Néri, C; Thompson, L; Marsh, L; Kazantsev, A; Luthi-Carter, R
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 81(2010)Supplement 1
Page Start:
A3
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. B13 NP03, a low dose lithium microemulsion, improves motor function and rescues striatal pathology without toxicity in the YAC128 mouse model of Huntington's disease. (16th November 2010)

Authors:
Pouladi, M A; Brilluad, E; Xie, Y; Franciosi, S; Zhang, W-N; Zapala, M; Compte, E; Poucheret, P; Maurel, J-C; Néri, C; Hayden, M R
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 81(2010)Supplement 1
Page Start:
A15
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. C06 The β-catenin repressor GSK-3β is a modifier of age at onset in Huntington's disease. (16th November 2010)

Authors:
Parker, J A; Tourette, C; Offner, N; Vazquez-Manrique, R; Mukhopadhyay, A; Darbois, A; Menet, S; Dolbeau, G; Schwenke, S; Maison, P; Orth, M; Brice, A; Dürr, A; Bachoud-Lévi, A-C; Tissenbaum, H A; Néri, C
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 81(2010)Supplement 1
Page Start:
A17
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search